AstraZeneca AB et al v. Changzhou Pharmaceutical Factory > Documents
Date Field | Doc. No. | Description (Pages) |
---|---|---|
Dec 30, 2022 | 26 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,425,934. (Attachments: # 1 Consent Judgment)(nms) (Entered: 12/30/2022) (Consent Judgment) (3) |
Dec 30, 2022 | 26 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,425,934. (Attachments: # 1 Consent Judgment)(nms) (Entered: 12/30/2022) (Main Document) (1) |
Dec 30, 2022 | 25 | CONSENT JUDGMENT. Signed by Judge Richard G. Andrews on 12/30/2022. (nms) (Entered: 12/30/2022) (3) |
Dec 28, 2022 | 24 | PROPOSED Consent Judgment, by AstraZeneca AB, AstraZeneca Pharmaceuticals, LP. (Silver, Daniel) Modified on 12/28/2022 (nms). (Entered: 12/28/2022) (3) |
Dec 16, 2022 | 23 | STIPULATION and Proposed Order to Extend Time - filed by Changzhou Pharmaceutical Factory. (Ormerod, Eve) Modified on 12/19/2022 (nms). (Entered: 12/16/2022) (1) |
Nov 14, 2022 | 22 | STIPULATION and Proposed Order to Extend Time - filed by Changzhou Pharmaceutical Factory. (Ormerod, Eve) Modified on 11/14/2022 (nms). (Entered: 11/14/2022) (1) |
Oct 13, 2022 | 21 | STIPULATION and Proposed Order to Extend Time - filed by Changzhou Pharmaceutical Factory. (Belgam, Neal) Modified on 10/14/2022 (nms). (Entered: 10/13/2022) (1) |
Sep 14, 2022 | 20 | STIPULATION and Proposed Order to Extend Time - filed by Changzhou Pharmaceutical Factory. (Ormerod, Eve) Modified on 9/14/2022 (nms). (Entered: 09/14/2022) (1) |
Aug 12, 2022 | 19 | STIPULATION and Proposed Order to Extend Time - filed by Changzhou Pharmaceutical Factory. (Ormerod, Eve) Modified on 8/13/2022 (nms). (Entered: 08/12/2022) (1) |
Jul 12, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [18] STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Changzhou Pharmaceutical Factory answer due 8/16/2022). Signed by Judge Richard G. Andrews on 7/12/2022. (nms) |
Jul 8, 2022 | 18 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Changzhou Pharmaceutical Factory. (Ormerod, Eve) Modified on 7/8/2022 (nms). |
Jun 21, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Ryan P. O'Quinn and Mark J. Feldstein for AstraZeneca AB and AstraZeneca Pharmaceuticals LP added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
Jun 21, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 24 in 21-cv-1116-RGA; D.I. 15 in 22-cv-354-RGA; D.I. 17 in 21-cv-1284-RGA) MOTION for Pro Hac Vice Appearance of Attorney Ryan P. O'Quinn and Mark J. Feldstein, filed by AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, AstraZeneca AB. Signed by Judge Richard G. Andrews on 6/21/2022. Associated Cases: 1:21-cv-01116-RGA, 1:21-cv-01284-RGA, 1:22-cv-00354-RGA(nms) |
Jun 20, 2022 | 17 | Certifications for Ryan P. O'Quinn and Mark J. Feldstein (2) |
Jun 20, 2022 | 17 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Ryan P. O'Quinn and Mark J. Feldstein - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited. (Attachments: # (1) Certifications for Ryan P. O'Quinn and Mark J. Feldstein)(Silver, Daniel) |
Jun 8, 2022 | 16 | Stipulation (1) Docket Text: STIPULATION and [Proposed] Order to Extend Time, by Changzhou Pharmaceutical Factory. (Ormerod, Eve) Modified on 6/8/2022 (nms). |
Jun 8, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [16] Stipulation and Proposed Order to Extend Time (*Reset Answer Deadlines: Changzhou Pharmaceutical Factory answer due 7/13/2022). Signed by Judge Richard G. Andrews on 6/8/2022. (nms) |
May 10, 2022 | 15 | Stipulation (1) Docket Text: STIPULATION and [Proposed] Order to Extend Time to answer, move, or otherwise respond to the Complaint by Changzhou Pharmaceutical Factory. (Ormerod, Eve) |
May 10, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [15] Stipulation and Proposed Order to Extend Time (*Reset Answer Deadlines: Changzhou Pharmaceutical Factory answer due 6/13/2022). Signed by Judge Richard G. Andrews on 5/10/2022. (nms) |
Apr 12, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [14] Stipulation and Proposed Order to Extend Time (*Reset Answer Deadlines: Changzhou Pharmaceutical Factory answer due 5/13/2022). Signed by Judge Richard G. Andrews on 4/12/2022. (nms) |
Apr 12, 2022 | 14 | Stipulation (1) Docket Text: STIPULATION and [Proposed] Order to Extend Time to answer, move, or otherwise respond to the Complaint by Changzhou Pharmaceutical Factory. (Ormerod, Eve) |
Mar 10, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [13] Stipulation and Proposed Order to Extend Time (*Reset Answer Deadlines: Changzhou Pharmaceutical Factory answer due 4/13/2022). Signed by Judge Richard G. Andrews on 3/10/2022. (nms) |
Mar 9, 2022 | 13 | Stipulation (1) Docket Text: STIPULATION and [Proposed] Order to Extend Time to answer, move, or otherwise respond to the Complaint by Changzhou Pharmaceutical Factory. (Ormerod, Eve) |
Feb 7, 2022 | 12 | Stipulation (1) Docket Text: STIPULATION and Proposed Order to Extend Time to answer, move, or otherwise respond to the Complaint by Changzhou Pharmaceutical Factory. (Ormerod, Eve) |
Feb 7, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [12] Stipulation and Proposed Order to Extend Time (*Reset Answer Deadlines: Changzhou Pharmaceutical Factory answer due 3/14/2022). Signed by Judge Richard G. Andrews on 2/7/2022. (nms) |
Feb 4, 2022 | 11 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Michael P. Kelly as co-counsel.. (Silver, Daniel) |
Jan 6, 2022 | 10 | Stipulation (1) Docket Text: STIPULATION and Proposed Order to Extend Time to answer, move, or otherwise respond to the Complaint by Changzhou Pharmaceutical Factory. (Ormerod, Eve) |
Jan 6, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] Stipulation and Proposed Order to Extend Time (*Reset Answer Deadlines: Changzhou Pharmaceutical Factory answer due 2/11/2022). Signed by Judge Richard G. Andrews on 1/6/2022. (nms) |
Dec 13, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [9] STIPULATION and Proposed Order to Extend Time to answer, move, or otherwise respond to the Complaint (*Reset Answer Deadlines: Changzhou Pharmaceutical Factory answer due 1/12/2022). Signed by Judge Richard G. Andrews on 12/13/2021. (nms) |
Dec 10, 2021 | 9 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION and Proposed Order to Extend Time to answer, move, or otherwise respond to the Complaint - filed by Changzhou Pharmaceutical Factory. (Ormerod, Eve) Modified on 12/13/2021 (nms). |
Nov 12, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [8] STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Changzhou Pharmaceutical Factory answer due 12/13/2021). Signed by Judge Richard G. Andrews on 11/12/2021. (nms) |
Nov 10, 2021 | 8 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Changzhou Pharmaceutical Factory. (Ormerod, Eve) Modified on 11/12/2021 (nms). |
Sep 15, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
Sep 14, 2021 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP: For Changzhou Pharmaceutical Factory waiver sent on 9/13/2021, answer due 11/12/2021. (Silver, Daniel) |
Sep 9, 2021 | 1 | Complaint* (1) |
Sep 9, 2021 | 6 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (twk) |
Sep 9, 2021 | 5 | Disclosure Statement (2) |
Sep 9, 2021 | 5 | Main Document (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB, AstraZeneca Pharmaceuticals LP filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Disclosure Statement)(twk) |
Sep 9, 2021 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,425,934. (twk) |
Sep 9, 2021 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No Earlier than July 26, 2021. Date of Expiration of Patent: April 17, 2030 (8,425,934).Thirty Month Stay Deadline: No Earlier than January 26, 2024.(twk) |
Sep 9, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) |
Sep 9, 2021 | 1 | Civil Cover Sheet (3) |
Sep 9, 2021 | 1 | Exhibit A (8) |
Sep 9, 2021 | 1 | Main Document (9) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Changzhou Pharmaceutical Factory - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3695656.) - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(twk) |